 |
 |

A New Dominant Spinocerebellar Ataxia Linked to Chromosome 19q13.4-qter
Zoran Brkanac, MD;
Laura Bylenok;
Magali Fernandez, MD;
Mark Matsushita, BS;
Hillary Lipe, NP;
John Wolff, BS;
David Nochlin, MD;
Wendy H. Raskind, MD, PhD;
Thomas D. Bird, MD
Arch Neurol. 2002;59:1291-1295.
Background The autosomal dominant spinocerebellar ataxias (SCAs) are a clinically
and genetically heterogeneous group of neurodegenerative disorders. Although
molecular genetic studies have so far implicated 16 loci in the etiology of
these diseases, approximately 30% of families with SCAs remain unlinked.
Objectives To report the location of a gene causing a "pure" autosomal dominant
cerebellar ataxia in one family and to describe the clinical phenotype.
Patients We have identified a 4-generation American family of English and Dutch
ethnicity with a pure cerebellar ataxia displaying an autosomal dominant pattern
of inheritance. The disease typically has its onset in the third and fourth
decades of life, shows no evidence of anticipation, progresses slowly, and
does not appear to decrease life expectancy. Clinical DNA testing excluded
SCA1, 2, 3, 6, 7, and 8.
Methods A genome-wide linkage analysis at a 10 centimorgan (cM) level was performed
with samples from 26 family members (11 affected, 10 clinically unaffected
at risk, and 5 spouses).
Results Assuming 90% penetrance, we found suggestive evidence of linkage to
chromosome 19, with a lod score of 2.49 for D19S571.
More detailed mapping in this region provided a maximum 2-point lod score
of 2.57 at = 0 for D19S254 and a maximum
multipoint lod score of 4.72 at D19S926. By haplotype
construction a 22-cM critical region from D19S601
to the q telomere was defined.
Conclusions We have mapped a gene for an autosomal dominant SCA to chromosome 19q13.4-qter
in one family. The critical region overlaps with the locus for SCA14, a disease
described in a single Japanese family and characterized by axial myoclonus.
Myoclonus was not seen in the family we studied, but it remains possible that
the 2 disorders are allelic variants.
From the Departments of Psychiatry (Dr Brkanac), Medicine (Ms Bylenok,
Messrs Matsushita and Wolff, and Drs Raskind and Bird), Neurology (Ms Lipe
and Dr Bird), and Pathology (Dr Nochlin), University of Washington School
of Medicine, Seattle; Department of Medicine, Ohio State University, Columbus
(Dr Fernandez); and Geriatric (Ms Lipe and Dr Bird) and VISN 20 Mental Illness
(Dr Raskind) Research, Education, and Clinical Centers, Veterans Affairs Puget
Sound Health Care System, Seattle.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Spinocerebellar ataxia type 14: study of a family with an exon 5 mutation in the PRKCG gene
Fahey et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1720-1722.
ABSTRACT
| FULL TEXT
The clinical and genetic spectrum of spinocerebellar ataxia 14
Chen et al.
Neurology 2005;64:1258-1260.
ABSTRACT
| FULL TEXT
Protein kinase C gamma mutations in spinocerebellar ataxia 14 increase kinase activity and alter membrane targeting
Verbeek et al.
Brain 2005;128:436-442.
ABSTRACT
| FULL TEXT
Mutation in the Catalytic Domain of Protein Kinase C {gamma} and Extension of the Phenotype Associated With Spinocerebellar Ataxia Type 14
Stevanin et al.
Arch Neurol 2004;61:1242-1248.
ABSTRACT
| FULL TEXT
Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family
van de Warrenburg et al.
Neurology 2003;61:1760-1765.
ABSTRACT
| FULL TEXT
Spinocerebellar Ataxia Type 14 Caused by a Mutation in Protein Kinase C {gamma}
Yabe et al.
Arch Neurol 2003;60:1749-1751.
ABSTRACT
| FULL TEXT
|